Kurt Deshayes

Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP).

M. Distefano, W. Fairbrother, K. Deshayes, 2003, Biochemistry.

Exploring Protein–Protein Interactions with Phage Display

Sachdev S Sidhu, S. Sidhu, W. Fairbrother, 2003, Chembiochem : a European journal of chemical biology.

IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.

Vishva M Dixit, V. Dixit, J. Blankenship, 2007, Cell.

c-IAP1 and c-IAP2 Are Critical Mediators of Tumor Necrosis Factor α (TNFα)-induced NF-κB Activation*

W. Fairbrother, K. Deshayes, K. Zobel, 2008, Journal of Biological Chemistry.

Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.

K. Das, G. Salvesen, W. Fairbrother, 2005, The Biochemical journal.

IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis

Vishva M. Dixit, V. Dixit, J. Blankenship, 2007, Cell.

Complex with a phage display-derived peptide provides insight into the function of insulin-like growth factor I.

Gerald Nakamura, Nicholas J Skelton, G. Nakamura, 2003, Biochemistry.

Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152).

Zhaoyang Wen, Brigitte Maurer, Vickie Tsui, 2012, Journal of medicinal chemistry.